Taiho Ventures Expands Investment Pool to $400 Million
Taiho Ventures, the strategic corporate venture capital arm of Taiho Pharmaceutical Co., Ltd., has announced that it is increasing its investment pool from $300 million to $400 million. This significant expansion highlights Taiho Ventures’ commitment to supporting innovative biotech start-ups in their pursuit of cutting-edge drug discovery activities. With this increased capital, Taiho Ventures aims to further accelerate its open innovation efforts in the oncology field.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
